Document is current
Any future updates will be listed below
-
Authors
Koa, Benjamin
Borja, Austin J.
Aly, Mahmoud
Padmanabhan, Sayuri
Tran, Joseph
Zhang, Vincent
Rojulpote, Chaitanya
Pierson, Sheila K.
Tamakloe, Mark-Avery
Khor, Johnson S.
Werner, Thomas J.
Fajgenbaum, David C.
Alavi, Abass
Revheim, Mona-Elisabeth https://orcid.org/0000-0003-3300-7420
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals
- License Information
-
More Information
Article History
Received: 1 November 2020
Accepted: 4 January 2021
First Online: 11 March 2021
Competing interests
: DCF has received research funding from EUSA Pharma for the ACCELERATE Registry (formerly sponsored by Janssen Pharmaceuticals). The rest of the authors declare no conflicts of interest.
: Clinical Trial ID: NCT02817997. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Not applicable.
